Dr. Huang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2351 Erwin Rd
Durham, NC 27705Phone+1 919-684-8111- Is this information wrong?
Summary
- I am an academic surgical pathologist. My goal is to improve human health through patient care of the highest quality, as well as performing laboratory research and educating physicians of the next generation
Education & Training
- Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 1999 - 2000
- NYU Grossman School of MedicineResidency, Pathology-Anatomic and Clinical, 1995 - 1999
- CUNY School of MedicinePhD, Molecular and Cellular Biology, 1987 - 1991
- Institute of Radiation MedicineMS, 1983 - 1986
- Anhui Medical UniversityClass of 1983
Certifications & Licensure
- CA State Medical License 2008 - 2026
- NC State Medical License 2015 - 2025
- NY State Medical License 1998 - 2010
- American Board of Pathology Anatomic Pathology & Clinical Pathology
Awards, Honors, & Recognition
- Roberta Nieberg Faculty Teaching Award UCLA Pathology and Laboratory Medicine, 2008
- Eric A. Schenk Award for Excellence in Pathology Education University of Rochester Medical Center, 2006
- Scientific Exchange Award Leukemia Society of America, 1993
- Join now to see all
Publications & Presentations
PubMed
- DNA methylation markers for risk of metastasis in a cohort of men with localized prostate cancer.Talar S Habeshian, Kimberly L Cannavale, Jeff M Slezak, Yu-Hsiang Shu, XuFeng Chen, Feng Shi, Kimberly D Siegmund, Stephen K Van Den Eeden, Chun R Chao, Gary W Chien, ...> ;Epigenetics. 2024 Dec 1
- Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer.Wen, Y., Tram, V., Chen, W., Li, C., Yeh, H., Thuy Dung, P., Jiang, K., Li, H., Hsiao, M., Chen, W., Liu, Y., Huang, J.> ;Cell Death & Disease. 2024 Jan 29
- UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas.Shiqin Liu, Timothy Chai, Fernando Garcia-Marques, Qingqing Yin, En-Chi Hsu, Michelle Shen, Angus Martin Shaw Toland, Abel Bermudez, Alifiani B Hartono, Christopher F ...> ;Cell Reports. Medicine. 2024 Feb 20
- Join now to see all
Journal Articles
- Reprogramming Normal Human Epithelial Tissues to a Common, Lethal Neuroendocrine Cancer LineageJiaoti Huang, John K Lee, Kim Nguyen, Science Magazine
- SRRM4 Gene Expression Correlates with Neuroendocrine Prostate CancerJiaoti Huang, MD, The Prostate
- Multiparametric Prostate MR Imaging: Impact on Clinical Staging and Decision MakingAriel A Schulman, Jiaoti Huang, Thomas J Polascik, Jamie N Holtz, ScienceDirect
- Join now to see all
Press Mentions
- Closing in on New Treatments for Prostate CancerFebruary 17th, 2023
- Tech Advances Are Enabling Faster, More Accurate Pathological Assessments of CancerApril 10th, 2022
- Meet the Mentors: School of Medicine PhD Students Support Their Peers Through New NetworkAugust 20th, 2021
- Join now to see all
Professional Memberships
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: